IRGCNursimulu, AnjaliFlorin, Marie-Valentine2018-09-052018-09-052018-09-052018-07-1810.5075/epfl-irgc-256776https://infoscience.epfl.ch/handle/20.500.14299/148143This report from a multi-stakeholder workshop on the ‘Economics of precision medicine’ addresses the issues of cost-effectiveness, as well as the need to revise how economic and social value can be valorised and financed, and to develop new business models for fundamentally personalised gene therapies with high up-front costs.IRGCprecision medicineeconomicscost-effectivenesstext::report::research report